Dr Surya is a co-founder of Curadev and serves as its Chief Executive Officer and Chief Scientific Officer . He founded Curadev along with his partner Manish Tandon in 2010 . In less than a decade , Curadev has emerged as one of India ' s rare drug discovery success stories with a slew of first in class small molecule patents that have emerged from its unique approach to target selection and drug discovery . Two of Curadev ' s lead drug candidates and programs have been licensed to top 10 big pharma companies . He has extensive experience in the assessment of drug molecules against several target classes across a range of therapeutic areas and specializes in building high performance research teams .
Previously Dr Surya has been associated with the leading organizations including SmithKline Beecham , Ranbaxy and TCG Lifesciences . He has played a founding role in establishing the biology and drug discovery teams in his various job roles .
Despite being a small molecule drug discovery biotech company , Curadev with an exciting portfolio of research programs has yielded many patent protected drug candidates . The team led by Dr Surya has created a premier translational research organization known for prescient target selection and high-quality , data-driven program execution . Its programs seek to ameliorate disease by translating cutting-edge discoveries into new medicines . Under his guidance , the company has swiftly established its credentials by successfully creating and out-licensing our small molecule patents to major pharmaceutical companies .
Under the leadership of Dr Surya , the company has created a Clinical Advisory Group ( CAG ) comprising of eminent oncologists to provide guidance in the design and execution of immuneoncology clinical trials with CRD3874 , its lead non nucleoside , allosteric small molecule STING agonist . The company recently received permission from the US FDA to commence FIH trials with systemically administered CRD3874 in patients with advanced metastatic solid cancers .
Current Position : Chief Executive Officer & Chief Scientific Officer , Curadev Pharma
Impact : Unique approach to target selection and drug discovery . Founded a drug discovery startups that continues to thrive despite lack of VC funds .
Alma Mater : IIT Kanpur ; Syracuse University , ( USA )
Dr Surya holds an integrated Masters in Physics from IIT Kanpur and a Ph . D . in Biophysics from Syracuse University , ( USA ). He specializes in building high performance research teams by creating nurturing research environments that value independent thinking and objectivity . He believes that the culture of letting science do the talking allows his team to find common ground and build alliances with scientists on the cutting edge of research in leading institutions across the world .
BioTech
BIOVOICENEWS . COM 35